MELANOMA 2009-2013 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Slides:

Advertisements

Similar presentations

Carcinogen - an agent known to cause cancer.

Advertisements

Content Standard 1.2 Cells can differentiate and may develop into complex multicellular organisms (i.e., cells, tissues, organs, organ systems, organisms).

BREAST CANCER IN IDAHO This PowerPoint presentation was created as a collaborative effort among the Cancer Data Registry of Idaho/ Idaho.

Sylvia Le April 29, Disparities in Health Care Disparities in health care have serious impact on the quality of health care. Identifying health.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

SEER PATTERNS OF CARE Kimberly Kimbler, MS, CCRP, CTR Kentucky Cancer Registry

How are cancer statistics kept up to date?.  Example:  Dx stage II colon cancer  Cancer has metastasized to the liver – 2009  How does the.

Basics of Pediatric Oncology Margret E. Merino, MD Pediatric Hematology/Oncology WRAMC.

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

Melanoma By Jeremy Postin. Melanoma Signs or Symptoms If you notice a mole that looks unusual or that has grown or changed color or shape If you notice.

AJCC TNM Staging 7th Edition Melanoma Case #2

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

Variations in Cancer Surgery Across the East Midlands and North Trent EMPHIN Forum (Apr 2010) Carolynn Gildea Trent Cancer Registry.

Cancer AN INTRODUCTION Cancer - An Introduction 1.

Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.

The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.

Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.

Lung Cancer Emily Cauchon Katie Reeves Emily Cauchon Katie Reeves.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.

Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

Pathology Report Colorectal Cancer Sahar Najibi April 11 th, 2008.

Melanoma By Blake Mednick. Introduction: Melanoma Causes the most deaths of all the skin cancers Begins in Melanocytes 1 in 65 people will be diagnosed.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

SEER Data Cancer Project Brett Langsjoen. SEER Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (NCI) Purpose: Collect.

Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

Radical vs Partial Nephrectomy for treatment of renal cell carcinoma at Prince Hussein Urology Centre Dr. Mohammad Alserhan Urology specialist Prince Hussein.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

What does the data tell us? Colorectal CANCER IN NEVADA

NON-SMALL CELL LUNG CANCER

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Johns Hopkins Hospital Malignant and Benign Brain/CNS

A graph of the 15-year survival curves comparing localized melanoma (Stages I and II), regional metastases (Stage III), and distant metastases (Stage IV).

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Johns Hopkins Hospital Cancer Registry

Shared Positive Affect Shared Negative Affect

تهیه کننده: استاد مربوطه: بهار 1392

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Lung Cancer (C33-C34): Number and Proportion of Cases Diagnosed at Each Stage, Adults 15-99, Former Anglia Cancer Network Percentage of Total.

4155 primary hepatocellular carcinoma with known diagnosis month/year

Oncology Madi Schacher R2.

NAACCR/IACR Combined Annual Conference 2019

Lung Cancer (C33-C34): 2011 Proportion of Cases Diagnosed at Each Stage, Adults (Aged 15-99), England and Wales Stage Adults Stage I 14.5% Stage II 7.3%

Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM

Shared Positive Affect Shared Negative Affect

Presentation transcript:

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014

HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800 MELANOMA ALL CASES = 1841 ANALYTIC vs. NON-ANALYTIC

HEAD/NECK OF THE SKIN AGE AT DIAGNOSIS, ALL CASES N = 1800 MELANOMA ALL CASES = 1841 AGE AT DIAGNOSIS

MELANOMA ALL CASES = 1841 RACE/ETHNICITY

MELANOMA ALL CASES = 1841 STATE OF RESIDENCE AT DIAGNOSIS

MELANOMA ALL MARYLAND CASES = 1389 COUNTY OF RESIDENCE AT DIAGNOSIS

MELANOMA ANALYTIC CASES = 1636* AJCC STAGE *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

MELANOMA ANALYTIC CASES TREATMENT BY STAGE AJCC 0 (472)AJCC I (724)AJCC II (186)AJCC III (178)AJCC IV (59) Surgery Only Radiation Only Immunotherapy Only Surgery & Radiation Surgery & Chemotherapy Surgery, Chemotherapy & Immunotherapy Surgery & Immunotherapy Radiation & Immunotherapy00000 Other Combinations No Treatment % *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

MELANOMA 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC *©SEER; SEER*STAT – SEER DOES NOT COLLECT MELANOMA INSITU

MELANOMA 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

MELANOMA 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

MELANOMA 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

MELANOMA 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT